Vanguard Group »

Akero Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $87M 3.7M 23.46
2024-03-31 $93M 3.7M 25.26
2023-12-31 $72M 3.1M 23.35
2023-09-30 $152M 3.0M 50.58
2023-06-30 $125M 2.7M 46.69
2023-03-31 $82M 2.1M 38.26
2022-12-31 $116M 2.1M 54.80
2022-06-30 $12M 1.3M 9.45
2022-03-31 $17M 1.2M 14.19
2021-09-30 $24M 1.1M 22.35
2021-06-30 $26M 1.1M 24.82
2021-03-31 $29M 986k 29.01
2020-12-31 $23M 884k 25.80
2020-09-30 $26M 854k 30.79
2020-06-30 $14M 540k 24.91
2020-03-31 $6.5M 307k 21.20
2019-12-31 $6.3M 285k 22.19
2019-09-30 $4.2M 185k 22.78